Tirzepatide Tirzepatide (Mounjaro / Zepbound / 穆桂諾)
4
conditions reviewed
A
top tier
A 🔵 A Moderate Evidence
Obesity
肥胖
Published with Warning 🚨 High market risk
→
A 🔵 A Moderate Evidence Type 2 Diabetes
第二型糖尿病
Published 🚨 High market risk
→
A 🔵 A Moderate Evidence Sleep Apnea
睡眠呼吸中止 (OSA)
Published with Warning 🚨 High market risk
→
B 🟡 B Preliminary Evidence Masld
脂肪肝 MASLD/MASH
Published with Warning 🚨 High market risk
→